University of New Mexico researchers have received funding to launch an early-stage clinical trial of a vaccine engineered to ...

Summary: New research uncovers how tau pathology spreads and damages synapses in progressive supranuclear palsy (PSP). Using ...

TORONTO -- An investigational antibody drug, designed to cross the blood-brain barrier (BBB) to eliminate amyloid-beta ...

UCSF researchers found the cancer drugs letrozole and irinotecan may reverse Alzheimer's effects, reducing tau protein clumps ...

What if your doctor could, when you turn 65, order a test that predicts whether you are going to develop Alzheimer’s dementia in your 70s or 80s? And what if – in case the test comes back ...

The term "dementia" may be less helpful than hindering. Here's why.

Acknowledging the limits of disease-modifying drugs like Leqembi and Kisunla, companies like Bristol Myers Squibb, Acadia, ...

This graphene foam biosensor offers high sensitivity for tau protein detection, enabling early Alzheimer's diagnosis and ...

Following a period of relative dormancy, research and development in the Alzheimer’s disease space is booming. And mounting attention, both in the development of disease modifying therapies (DMTs) and ...

It also boosts the immune system, with the mucus containing antibodies that can attack ... by the development of amyloid plaques and tau tangles in the brain - which damage and kill cells. Amyloid ...